6 juin (Reuters) - Merck KGaA MRCG.DE : * MERCK AND RIGAKU FORM PARTNERSHIP TO DEVELOP NOVEL MOLECULAR STRUCTURE ANALYSIS TECHNOLOGY * MERCK AND RIGAKU CORP. HAVE SIGNED A JOINT DEVELOPMENT AGREEMENT TO DEVELOP LAB CONSUMABLES BASED ON HIGHLY INNOVATIVE CRYSTALLINE SPONGE TECHNOLOGY * MERCK AND RIGAKU ARE COLLABORATING TO DEVELOP COMMERCIALLY AVAILABLE LAB SOLUTIONS EMPLOYING HIGHLY INNOVATIVE CRYSTALLINE SPONGE TECHNOLOGY * MERCK WILL DEVELOP LAB CONSUMABLES TO DETERMINE THE ABSOLUTE CHEMICAL STRUCTURE OF SUBSTANCES ON SUB-MICROGRAM SCALE Source text: https://bit.ly/2EVVspJ Further company coverage: MRCG.DE (Berlin Speed Desk)
Connectez-vous pour conserver cet article et le lire plus tard.
Nouveau sur Boursorama ?
Devenez membre gratuitement
BRIEF-Merck KGaA Partners With Japan’S Rigaku To Develop Molecular Analysis Technology
information fournie par Reuters 06/06/2019 à 15:09
| XETRA | +0.36% |
© 2024 Thomson Reuters. All rights reserved.
Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies.
Mes listes
Message d'alerte
Une erreur est survenue pendant le chargement de la liste
Cette liste ne contient aucune valeur.
0 commentaire
Vous devez être membre pour ajouter un commentaire.
Vous êtes déjà membre ? Connectez-vous
Pas encore membre ? Devenez membre gratuitement
Signaler le commentaire
Fermer